Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Catalytica Fine Chemicals appoints board of directors.


MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Feb. 14, 1995-- Catalytica Fine Chemicals, Inc., recently formed as a wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 of Catalytica, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CTAL CTAL Confederacion de Trabajadores de America Latina (Confederation of Latin American Workers)
CTAL Canadian Tire Acceptance Limited
CTAL Computer Technology Application Lab, Inc.
CTAL Confidentially Typed Assembly Language
), announced Tuesday that it has appointed a board of directors which includes Barry M. Bloom, retired Executive Vice President, R&D, Pfizer, Inc.; Thomas L. Gutshall, President and Chief Operating Officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
 of CV Therapeutics; and Richard Fleming Richard Fleming (born around 1360; died January 25 or January 26, 1431, in Sleaford Castle), Bishop of Lincoln, and founder of Lincoln College, Oxford, was born at Crofton in Yorkshire.

He was descended from a good family, and was educated at University College, Oxford.
, President, Richard Fleming Associates, Inc.

Barry M. Bloom brings more than 40 years of pharmaceutical company experience at Pfizer to Catalytica Fine Chemicals. He has served in executive level positions at Pfizer since 1971, serves as a director of several pharmaceutical companies, and was a member of the U.S. Congressional Commission on the Federal Drug Approval Process.

Bloom's thorough understanding of the research, development, and drug manufacturing process will help provide Catalytica Fine Chemicals with a customer perspective as the business forms new partnerships and develops and manufactures new products for pharmaceutical companies.

Thomas L. Gutshall has 35 years of experience in specialty chemicals, pharmaceuticals, and diagnostics, including 12 years at Mallinckrodt Inc. and 12 years at Syntex Corp., where he was responsible for returning Syva Co. to profitability. His expertise in manufacturing operations Manufacturing operations concern the operation of a facility, as opposed to maintenance, supply and distribution, health, and safety, emergency response, human resources, security, information technology and other infrastructural support organizations. , productivity improvement, and acquisitions should be an invaluable asset to Catalytica Fine Chemicals as the business grows.

Richard Fleming has 40 years of experience in the chemical industry, including more than 20 years in executive positions having served as President and Chief Operating Officer of Avisun Corp., Executive Vice President of Air Products and Chemicals, President and Chief Operating Officer of GAF GAF Global Assessment of Functioning
GAF German Air Force
GAF General Aniline & Film
GAF Gender AIDS Forum (South Africa)
GAF Ghana Armed Forces
GAF Get A Freelancer (freelance services website) 
 Corp., and President of Catalytica. He is currently President of the management consulting Noun 1. management consulting - a service industry that provides advice to those in charge of running a business
service industry - an industry that provides services rather than tangible objects
 firm Richard Fleming Associates and is a director of Catalytica. He has advised Catalytica Fine Chemicals since its inception in 1993.

James A. Cusumano, President of Catalytica Fine Chemicals, said, "Barry, Tom and Dick bring a wealth of complementary experience to our organization. They provide both the customer and supplier perspectives and each has played a critical role in growing major enterprises relevant to Catalytica Fine Chemicals' business."

Catalytica Fine Chemicals, Inc., a wholly owned subsidiary of Catalytica, Inc., is a manufacturer of fine chemical building blocks for the pharmaceutical industry. Catalytica is developing catalytic processes and is manufacturing products that are designed to prevent pollution economically.

CONTACT: Catalytica

Alice Galloway, 415/940-6382
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 14, 1995
Words:384
Previous Article:Multi-Tech licenses simultaneous voice and data modem technology.
Next Article:Oak Technology Inc. offers 4,750,000 shares of common stock at $14 per share.
Topics:



Related Articles
Catalytica Fine Chemicals Inc. Announces $15 Million Investment by Pfizer.
Catalytica to Buy Glaxo Wellcome Pharmaceutical Plant in Greenville, N.C.
Catalytica Reports Third Quarter and Nine Months Results.
Catalytica Reports Strong Fourth Quarter and 1999 Financial Results.
People in the News.
People in the News.
Catalytica to Sell Pharmaceutical Operations to DSM and Spin-off Remaining Businesses to Stockholders.
DSM Acquires Catalytica Pharmaceuticals.
BASF.
Career moves.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles